Hermetica Superfood Encyclopedia
The Short Answer
Achillea fragrantissima contains sesquiterpene lactones (notably achillolide A), flavonoids (including 3,5,4'-trihydroxy-6,7,3'-trimethoxyflavone), and thujone-rich essential oils that modulate amyloid precursor protein processing, suppress oxidative stress, and exert antibacterial activity through multiple molecular mechanisms. In APPswe/PS1ΔE9 transgenic mice treated for one month, cortical full-length amyloid precursor protein was upregulated without increasing amyloid-β40/42 or tau phosphorylation, while rat oral extracts at 300–500 mg/kg significantly elevated total antioxidant capacity (5.88±1.32) and superoxide dismutase activity (7.66±1.18) compared to controls.
CategoryHerb
GroupMiddle Eastern
Evidence LevelPreliminary
Primary KeywordAchillea fragrantissima benefits
Fragrant Yarrow — botanical close-up
Health Benefits
**Anti-inflammatory Activity**
Methanolic extracts and essential oil components including α-thujone modulate inflammatory pathways, reducing oxidative stress markers in rat models at oral doses of 300–500 mg/kg; the precise cytokine targets remain under preclinical investigation. **Antioxidant Capacity Enhancement**: Oral administration of A
fragrantissima extract in Wistar rats significantly increased total antioxidant capacity (5.88±1.32) and superoxide dismutase levels (7.66±1.18) compared to untreated controls, indicating upregulation of endogenous antioxidant defense enzymes. **Neuroprotective Potential**
The purified sesquiterpene lactone achillolide A (AcA) at 100 µM and flavonoid TTF at 8 µM upregulated full-length amyloid precursor protein in HEK-APPswe cells and transgenic mouse cortex without increasing neurotoxic amyloid-β peptides, suggesting a disease-modifying role in Alzheimer's-related amyloidogenesis.
**Antibacterial Properties**
Essential oils extracted by hydrodistillation (α-thujone 20.38%, piperatone 12.09%) and hydrosoaking (α-thujone 29.37%, artemisia ketone 19.59%) demonstrated antibacterial activity against multiple strains in agar well diffusion assays, attributed to membrane-disrupting oxygenated monoterpenes.
**Microglial and Astrocyte Protection**
Achillolide A reduced microglial activation and protected astrocytes against hydrogen peroxide-induced oxidative cell death in vitro, pointing to a dual neuroprotective mechanism targeting neuroinflammation and reactive oxygen species simultaneously. **Immunomodulatory Effects**
High-dose rat extracts (500 mg/kg) produced measurable immune modulation comparable in study design to reference compounds Echinaid and Endoxan, suggesting T-cell and antioxidant enzyme pathway engagement, though mechanistic detail remains preliminary. **Fatty Acid and Phytochemical Richness**
GC-MS profiling of leaf extracts identified oleic acid (35.30%) and palmitic acid (up to 20.99% under environmental stress), alongside steroids and flavonoids that collectively contribute to membrane-stabilizing and receptor-modulatory bioactivities.
Origin & History
Natural habitat
Achillea fragrantissima is a perennial aromatic desert shrub native to arid and semi-arid regions of the Middle East and North Africa, including the Sinai Peninsula, Negev Desert, Arava Valley of Israel, and parts of Egypt and the Arabian Peninsula. It thrives in rocky wadis, desert plains, and sandy soils under extreme heat and low rainfall, adaptations reflected in its high concentration of volatile terpenoids and stress-induced fatty acid accumulation. The plant has been ethnobotanically documented across Egyptian, Israeli, and broader Arabian traditional medicine systems, where it is gathered from wild populations rather than cultivated commercially.
“Achillea fragrantissima has been employed for centuries in traditional Arabian and Egyptian medicine as a remedy for inflammatory conditions, gastrointestinal complaints, and respiratory ailments, with dried and fresh flower infusions constituting the primary preparation method documented in ethnobotanical literature. The plant's vernacular name in Arabic-speaking regions reflects its intensely aromatic character, and it holds a place in Bedouin folk medicine as a wild-harvested desert medicinal, particularly in Sinai and Negev populations where it grows abundantly in rocky terrain. Authenticated herbarium specimens collected from the Arava Valley of Israel have been deposited in botanical collections supporting modern phytochemical research, bridging traditional knowledge with contemporary pharmacognosy. The genus Achillea more broadly carries a rich historical legacy tracing to ancient Greek medicine — the genus name references the mythological hero Achilles, reputed to have used yarrow species for wound healing — situating A. fragrantissima within one of the oldest continuously documented medicinal plant lineages in the Old World.”Traditional Medicine
Scientific Research
The entire evidence base for Achillea fragrantissima consists exclusively of preclinical studies — in vitro cell assays and rodent experiments — with zero published human clinical trials, representing a significant limitation in translational confidence. Mouse studies used APPswe/PS1ΔE9 double-transgenic Alzheimer's models (treatment duration one month, age six months) and demonstrated cortical FL-AβPP upregulation by AcA (100 µM) and TTF (8 µM) without Aβ or tau changes, but sample sizes were not fully specified and effect sizes were not reported as standardized metrics such as Cohen's d. Wistar rat immunomodulation studies employed oral extract doses of 300–500 mg/kg and reported statistically significant elevations in total antioxidant capacity and superoxide dismutase versus controls (p<0.05), with comparators including Echinaid and Endoxan, though blinding status and randomization methodology were not detailed in available data. Essential oil composition studies employed GC-MS profiling across four extraction methods (HD, HS, MAHD, SF), providing robust phytochemical characterization but no pharmacodynamic outcomes, and the antibacterial agar well diffusion assays lacked minimum inhibitory concentration values in the summarized data.
Preparation & Dosage
Traditional preparation
**Traditional Infusion (Dry or Fresh Flowers)**
Prepared as an herbal tea in Arabian traditional medicine; no standardized quantity established, typically prepared as a light infusion by regional practitioners.
**Methanolic Leaf Extract (Preclinical Oral)**
300–500 mg/kg in Wistar rat studies; no human equivalent dose established; direct extrapolation not supported without allometric scaling and pharmacokinetic data
Used at .
**Purified Sesquiterpene Lactone (AcA) — In Vitro**
25 mg/mL stock concentration; no oral formulation data available
Tested at 100 µM in HEK-APPswe cells over 72 hours; dissolved in DMSO at .
**Purified Flavonoid (TTF) — In Vitro**
Active at 8 µM in cell culture over 72 hours; no human dosage equivalent established.
**Essential Oil (Hydrodistillation or Hydrosoaking)**
Characterized for composition via GC-MS; antibacterial activity demonstrated in agar well diffusion but no effective dose range for human use quantified.
**Standardization**
No commercial standardization protocols exist; no specification for sesquiterpene lactone or thujone percentage in any marketed product form has been established in the literature.
**Timing and Administration Notes**
All preclinical oral data is from acute-to-subchronic rodent models; optimal timing, frequency, and formulation for human use remain entirely undetermined.
Nutritional Profile
Achillea fragrantissima is not consumed as a dietary food source and lacks conventional macronutrient or micronutrient data; its nutritional significance lies primarily in its dense phytochemical composition. Key identified compounds include oleic acid (35.30% of leaf extract fatty acid fraction) and palmitic acid (up to 20.99% under heat/drought stress conditions), reflecting a fatty acid profile with potential membrane-stabilizing properties. Essential oil fractions are dominated by oxygenated monoterpenes: α-thujone (20.38–29.37% depending on extraction method), piperatone (12.09% by hydrodistillation), artemisia ketone (19.59% by hydrosoaking), and santolina alcohol (14.66%), alongside camphor (1.80–2.68%), borneol (0.96%), and artemisia acetate (1.67–3.47%). Polar extract fractions contain flavonoids (including TTF), sesquiterpene lactones (including achillolide A), steroids, and α-resorcylic acid; bioavailability of all these compounds in humans is unstudied, and the high thujone content of essential oils raises concerns about oral bioavailability thresholds analogous to those established for Artemisia species.
How It Works
Mechanism of Action
Achillolide A (AcA), a guaianolide sesquiterpene lactone, and the methoxylated flavonoid 3,5,4'-trihydroxy-6,7,3'-trimethoxyflavone (TTF) appear to modulate amyloid precursor protein (AβPP) processing by influencing α-secretase or β/γ-secretase (μ-secretase) activity, stabilizing full-length AβPP (~110 kDa) while reducing its amyloidogenic cleavage into Aβ40 and Aβ42 peptides, as demonstrated in both HEK-APPswe cell lines and APPswe/PS1ΔE9 transgenic mouse cortex. AcA additionally suppresses microglial hyperactivation and attenuates H₂O₂-induced astrocyte death in vitro, likely through inhibition of NF-κB-mediated neuroinflammatory signaling and scavenging of reactive oxygen species via its α,β-unsaturated lactone moiety, which can form covalent adducts with thiol groups on inflammatory enzyme active sites. Essential oil monoterpenoids, particularly α-thujone and piperatone, disrupt bacterial membrane integrity through hydrophobic intercalation, while camphor and borneol contribute to anti-inflammatory effects likely via TRPM8 receptor modulation and prostaglandin synthesis inhibition. Methanolic extract fractions containing flavonoids and steroids upregulate endogenous antioxidant enzymes including superoxide dismutase, suggesting transcriptional activation of Nrf2/ARE pathway targets in rat immune tissues.
Clinical Evidence
No human clinical trials have been conducted on Achillea fragrantissima in any indication, including its primary traditional use as an anti-inflammatory agent in Egyptian and Arabian medicine. Available preclinical data from transgenic mouse models suggest a neuroprotective mechanism involving AβPP processing modulation, and rat oral administration studies indicate dose-dependent antioxidant enzyme upregulation at 300–500 mg/kg, but these findings cannot be extrapolated to effective human doses without pharmacokinetic and phase I safety data. The absence of standardized outcome measures, reported confidence intervals, and effect size calculations in the available rodent studies further limits the strength of conclusions that can be drawn. Rigorous controlled human trials are required before any clinical recommendations can be made for this botanical ingredient.
Safety & Interactions
Formal human safety data for Achillea fragrantissima does not exist; all available tolerability information derives from preclinical rodent studies in which oral extract doses up to 500 mg/kg produced no overt signs of acute toxicity and were associated with immune-supportive outcomes rather than adverse effects. However, the essential oil's high α-thujone content (20–29% depending on extraction method) raises a theoretical neurotoxicity concern, as thujone is a GABA-A receptor antagonist documented to cause convulsions and CNS excitation at sufficient doses in both animal models and historical human exposures with absinthe; this risk has not been directly tested for A. fragrantissima EO specifically. No drug interaction data exists for this species; by structural analogy, sesquiterpene lactone-containing herbs may inhibit cytochrome P450 enzymes or potentiate anticoagulant medications, but this is entirely speculative in the absence of pharmacokinetic studies. Pregnancy and lactation safety is undetermined; given the thujone content and complete absence of reproductive toxicology data, use during pregnancy should be avoided until safety is formally established.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Achillea fragrantissimaFragrant YarrowQaysumdesert yarrowbu'aythiran
Frequently Asked Questions
What is Achillea fragrantissima used for in traditional medicine?
In Arabian and Egyptian traditional medicine, Achillea fragrantissima has been used primarily as an anti-inflammatory remedy, with dried or fresh flower infusions prepared to treat general inflammatory conditions, gastrointestinal complaints, and respiratory ailments. The plant grows wild in Sinai, Negev, and Arava desert regions and is a well-documented component of Bedouin folk medicine, though no clinical trials have validated these traditional uses in humans.
Does Achillea fragrantissima have any evidence for Alzheimer's disease?
Preclinical research has identified two purified compounds from A. fragrantissima — the sesquiterpene lactone achillolide A (AcA, 100 µM) and the flavonoid TTF (8 µM) — that upregulate full-length amyloid precursor protein in both HEK-APPswe cells and APPswe/PS1ΔE9 transgenic mouse cortex without increasing neurotoxic amyloid-β40/42 or tau phosphorylation. These findings are preliminary and entirely preclinical; no human trials have been conducted, and direct clinical application to Alzheimer's disease cannot be recommended at this stage.
Is Achillea fragrantissima essential oil safe to use?
Safety data for A. fragrantissima essential oil in humans is absent; the oil contains 20–29% α-thujone depending on extraction method (hydrodistillation vs. hydrosoaking), and thujone is a known GABA-A receptor antagonist that can cause neurotoxicity and convulsions at high doses as documented in other thujone-rich plant products. Rodent extract studies up to 500 mg/kg showed no overt toxicity for methanolic extracts, but essential oil-specific safety studies have not been performed, and caution is warranted particularly in pregnancy or with concurrent CNS medications.
What bioactive compounds are found in Achillea fragrantissima?
GC-MS and phytochemical analyses have identified sesquiterpene lactones (achillolide A), flavonoids (3,5,4'-trihydroxy-6,7,3'-trimethoxyflavone), fatty acids (oleic acid 35.30%, palmitic acid up to 20.99%), and essential oil components including α-thujone (20–29%), piperatone (12.09%), artemisia ketone (19.59%), santolina alcohol (14.66%), camphor (1.80–2.68%), borneol (0.96%), and artemisia acetate (1.67–3.47%). Additional minor constituents include strophanthidin, dihydroxanthin, α-resorcylic acid, and various steroids contributing to the plant's antibacterial and antioxidant activities.
What is the effective dose of Achillea fragrantissima extract?
No standardized human dose has been established for any preparation of Achillea fragrantissima. Preclinical rat oral studies used methanolic extract doses of 300–500 mg/kg, with the higher dose producing significantly elevated total antioxidant capacity (5.88±1.32) and superoxide dismutase levels (7.66±1.18); these rodent doses cannot be directly converted to human equivalents without allometric scaling and formal pharmacokinetic characterization. In vitro studies used purified achillolide A at 100 µM and TTF at 8 µM, but oral bioavailability of these isolated compounds in humans is completely unstudied.
Does Achillea fragrantissima interact with common medications?
Achillea fragrantissima contains α-thujone and other volatile compounds that may interact with cytochrome P450 enzymes, potentially affecting metabolism of certain medications including anticoagulants and anticonvulsants. While preclinical data suggests modulatory effects on inflammatory pathways, clinical drug interaction studies in humans are limited. Consult a healthcare provider before combining with prescription medications, especially blood thinners or drugs with narrow therapeutic windows.
Is Achillea fragrantissima safe during pregnancy and breastfeeding?
Achillea fragrantissima, particularly its essential oil containing α-thujone, is traditionally contraindicated during pregnancy due to potential uterotonic effects, though rigorous clinical evidence in humans is lacking. Safety data for breastfeeding populations is similarly insufficient. Pregnant and nursing women should avoid supplementation with this herb until adequate human safety studies are conducted.
What does current research show about Achillea fragrantissima's anti-inflammatory effectiveness in humans?
Most evidence for Achillea fragrantissima's anti-inflammatory activity comes from animal studies (rat models) using oral doses of 300–500 mg/kg, which demonstrate reduced oxidative stress markers and modulation of inflammatory pathways. Clinical trials in humans remain sparse, limiting confidence in translating animal findings to real-world supplementation. Stronger human research is needed to establish efficacy and optimal dosing for inflammatory conditions.
Conditions This May Help
Based on the mechanism and research, Achillea fragrantissima (Achillea fragrantissima) may support the following health areas. Each link goes to an evidence-ranked guide of the best ingredients for that concern.
Inflammation & Joint Health
Top anti-inflammatories: turmeric, boswellia, omega-3, ginger. Evidence on NF-κB modulation and joint support.
Browse evidence-ranked ingredients →
Antioxidant Protection
Top antioxidants: astaxanthin, glutathione, vitamin E, resveratrol. Evidence on oxidative stress protection.
Browse evidence-ranked ingredients →
Immune System Support
Top immune boosters: reishi, chaga, elderberry, vitamin C, zinc. Clinical evidence on immune modulation.
Browse evidence-ranked ingredients →
Detox & Liver Support
Liver support supplements: milk thistle, NAC, dandelion, glutathione. Evidence on hepatoprotection and detox.
Browse evidence-ranked ingredients →
Stress & Cortisol
Top adaptogens for stress: ashwagandha, rhodiola, holy basil. Clinical evidence on cortisol reduction and HPA …
Browse evidence-ranked ingredients →
Cognitive Function & Focus
Top nootropics: lion's mane, bacopa, ginkgo, phosphatidylserine. PubMed-cited evidence on cognitive enhancemen…
Browse evidence-ranked ingredients →
Or jump to the curated Best Inflammation & Joint Health Stack → top 12 evidence-ranked ingredients.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w achillea-fragrantissima-achillea-fragrantissima curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
